Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL
Publication date :
2013
Journal title :
Belgian Journal of Hematology
ISSN :
2033-3749
Publisher :
Ariez Medical Publishing, Amsterdam, Netherlands
Volume :
4 (2)
Pages :
51-57
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
The guidelines for adult patients in this article are based on 2011 ESMO and NCCN version 4.2011 guidelines and amended for the particular Belgian context of label prescription and reimbursement. Levels of evidence for the use of treatment recommandations are given in square brackets. Statements without grading were considered justified standard clinical practice by the experts of the BHS-lymphoma working party.